Invivoscribe Boost CAR-T therapy with CERo Therapeutics Ph1 Trial
08 Jul 2025 //
BUSINESSWIRE
CERo Gets FDA Orphan Tag for CER-1236 to Treat AML
17 Jun 2025 //
PRESS RELEASE
CERo Announces Publication Supporting Use of Candidate CER-1236
07 Mar 2024 //
BUSINESSWIRE